Suppr超能文献

葡萄糖还是脂肪作为非蛋白质能量来源?一项针对需要静脉营养的胃肠病患者的对照临床试验。

Glucose or fat as a nonprotein energy source? A controlled clinical trial in gastroenterological patients requiring intravenous nutrition.

作者信息

Macfie J, Smith R C, Hill G L

出版信息

Gastroenterology. 1981 Jan;80(1):103-7.

PMID:6778757
Abstract

The best nonprotein energy source for routine use in patients receiving intravenous nutrition (IVN) for short periods of time is not known. In particular the relative merits of glucose and fat remain controversial. The present study was undertaken to determine if a quantitative difference in the ability to retain nitrogen could be documented between these two energy sources. In a prospective study of two comparable groups of 16 gastroenterologic patients who received IVN for 2 wk the changes in body weight, fat, water, and protein that occurred were measured. The only difference in the IVN between the groups was the nonprotein energy source. Group I received hypertonic glucose alone (49.2 +/- 7.9 kcal/kg day), and group II received an intravenous fat emulsion (60% of the nonprotein energy) in addition to hypertonic glucose (51.5 +/- 5.0 kcal/kg/day). Significant weight gain occurred in both groups (p < 0.001). In group I this was acounted for by gains of water (p < 0.02) and fat (p < 0.01) but not of protein. Patients receiving glucose together with fat (group II) gained protein (p < 0.02), but the gains of fat and water were not significant. Our study shows that protein repletion was achieved with an intravenous fat emulsion over a 2-wk period and the problems of water retention which occurred in the patients fed with glucose alone was not present. The results suggest that the fat in conjunction with glucose may be more effective as an energy source than equicaloric amounts of glucose alone in the type of patients we have studied.

摘要

对于短期接受静脉营养(IVN)的患者,常规使用的最佳非蛋白质能量来源尚不清楚。特别是葡萄糖和脂肪的相对优点仍存在争议。本研究旨在确定这两种能量来源在保留氮的能力上是否存在定量差异。在一项前瞻性研究中,对两组各16名接受2周IVN的胃肠病患者进行了比较,测量了他们体重、脂肪、水分和蛋白质的变化。两组IVN的唯一区别在于非蛋白质能量来源。第一组仅接受高渗葡萄糖(49.2±7.9千卡/千克·天),第二组除高渗葡萄糖(51.5±5.0千卡/千克·天)外,还接受静脉脂肪乳剂(占非蛋白质能量的60%)。两组均出现显著体重增加(p<0.001)。在第一组中,体重增加是由水分(p<0.02)和脂肪(p<0.01)增加引起的,而非蛋白质增加。接受葡萄糖和脂肪联合治疗的患者(第二组)蛋白质增加(p<0.02),但脂肪和水分增加不显著。我们的研究表明,在两周内静脉脂肪乳剂可实现蛋白质补充,且单独接受葡萄糖喂养的患者出现的水分潴留问题不存在。结果表明,在我们所研究的这类患者中,脂肪与葡萄糖联合作为能量来源可能比等量葡萄糖单独使用更有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验